A team of highly qualified professionals with technical expertise are tirelessly working together in developing new and innovative devices for the treatment of three common congenital heart defects: Patent ductus arteriosus (PDA), Ventricular septal defect (VSD), and Patent foramen ovale (PFO).

PDA, VSD, and PFO are all congenital heart defects that can cause various complications and health issues. PDA occurs when a blood vessel called the ductus arteriosus fails to close after birth.

VSD occurs when there is a hole in the wall separating the heart’s two lower chambers.

PFO is a condition where a small opening between the heart’s upper chambers fails to close after birth. The development of new and innovative devices for the treatment of these conditions is critical, as traditional treatment options like open-heart surgery can be invasive and carry significant risks.